首页> 外文期刊>Reviews of physiology, biochemistry and pharmacology. >α_1-Adrenergic signaling mechanisms in contraction of resistance arteries
【24h】

α_1-Adrenergic signaling mechanisms in contraction of resistance arteries

机译:α_1-肾上腺素能信号传导机制在阻力动脉收缩中的作用

获取原文
获取原文并翻译 | 示例
       

摘要

Our goal in this review is to provide a comprehensive, integrated view of the numerous signaling pathways that are activated by α_1-adrenoceptors and control actin-myosin interactions (i.e., crossbridge cycling and force generation) in mammalian arterial smooth muscle. These signaling pathways may be categorized broadly as leading either to thick (myosin) filament regulation or to thin (actin) filament regulation. Thick filament regulation encompasses both "Ca~(2+) activation" and "Ca~(2+)-sensitization" as it involves both activation of myosin light chain kinase (MLCK) by Ca~(2+)-calmodulin and regulation of myosin light chain phosphatase (MLCP) activity. With respect to Ca~(2+) activation, adrenergically induced Ca~(2+) transients in individual smooth muscle cells of intact arteries are now being shown by high resolution imaging to be sarcoplasmic reticulum-dependent asynchronous propagating Ca~(2+) waves. These waves differ from the spatially uniform increases in [Ca~(2+)] previously assumed. Similarly, imaging during adrenergic activation has revealed the dynamic translocation, to membranes and other subcellular sites, of protein kinases (e.g., Ca~(2+)-activated protein kinases, PKCs) that are involved in regulation of MLCP and thus in "Ca~(2+) sensitization" of contraction. Thin filament regulation includes the possible disinhibition of actin-myosin interactions by phosphorylation of CaD, possibly by mitogen-activated protein (MAP) kinases that are also translocated during adrenergic activation. An hypothesis for the mechanisms of adrenergic activation of small arteries is advanced. This involves asynchronous Ca~(2+) waves in individual SMC, synchronous Ca~(2+) oscillations (at high levels of adrenergic activation), Ca~(2+) sparks, "Ca~(2+)-sensitization" by PKC and Rho-associated kinase (ROK), and thin filament mechanisms.
机译:我们在这篇综述中的目标是提供哺乳动物动脉平滑肌中被α_1-肾上腺素受体激活并控制肌动蛋白-肌球蛋白相互作用(即跨桥循环和产生力)的众多信号通路的全面综合视图。这些信号传导途径可大致归类为导致厚(肌球蛋白)细丝调节或导致细(肌动蛋白)细丝调节。粗丝调节既包括“ Ca〜(2+)激活”又包括“ Ca〜(2 +)-致敏”,因为它既涉及Ca〜(2 +)-钙调蛋白对肌球蛋白轻链激酶(MLCK)的激活又包括对Ca〜(2 +)-钙调蛋白的调节。肌球蛋白轻链磷酸酶(MLCP)活性。关于Ca〜(2+)的激活,高分辨率成像显示肾上腺素诱导的完整动脉单个平滑肌细胞中的Ca〜(2+)瞬变是肌浆网依赖性的异步传播Ca〜(2+)。波浪。这些波不同于先前假定的[Ca〜(2+)]中的空间均匀增加。同样,肾上腺素激活过程中的成像显示,蛋白激酶(例如,Ca〜(2+)激活的蛋白激酶,PKCs)动态迁移到膜和其他亚细胞部位,这些蛋白激酶参与了MLCP的调控,因此参与了“ Ca收缩的“〜(2+)致敏”。细丝调节包括可能通过CaD磷酸化来抑制肌动蛋白-肌球蛋白相互作用,可能是通过在肾上腺素能激活过程中也易位的促分裂原活化蛋白(MAP)激酶引起的。提出了小动脉肾上腺素能激活机制的假说。这涉及单个SMC中的异步Ca〜(2+)波,同步Ca〜(2+)振荡(在高水平的肾上腺素激活下),Ca〜(2+)火花,“ Ca〜(2 +)-敏化” PKC和Rho相关激酶(ROK),以及细丝机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号